{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:08:39Z","timestamp":1773792519598,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T00:00:00Z","timestamp":1710547200000},"content-version":"am","delay-in-days":350,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jaad.2022.11.040","type":"journal-article","created":{"date-parts":[[2022,12,18]],"date-time":"2022-12-18T23:24:34Z","timestamp":1671405874000},"page":"808-815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Impact of systemic therapies in metastatic melanoma of unknown primary: A study from MELBASE, a French multicentric prospective cohort"],"prefix":"10.1016","volume":"88","author":[{"given":"Perrine","family":"Rousset","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Dalle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Mortier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Dereure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Dalac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Dutriaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Th\u00e9r\u00e8se","family":"Leccia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delphine","family":"Legoupil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Brunet-Possenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"De Quatrebarbes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Jacques","family":"Grob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Saiag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eve","family":"Maubec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Emmanuel","family":"Stoebner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Granel-Brocard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Philippe","family":"Arnault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Allayous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bastien","family":"Oriano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9leste","family":"Lebbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henri","family":"Montaudi\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jaad.2022.11.040_bib1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ijc.11360","article-title":"Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in Western Europe and decreases in Scandinavia","volume":"107","author":"De Vries","year":"2003","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.jaad.2022.11.040_bib2","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.ejca.2012.09.005","article-title":"Melanoma of unknown primary origin: a population-based study in the Netherlands","volume":"49","author":"De Waal","year":"2013","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1016\/j.jaad.2022.11.040_bib3","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G","article-title":"The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society","volume":"83","author":"Chang","year":"1998","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.jaad.2022.11.040_bib4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaad.2014.09.029","article-title":"Metastatic melanomas of unknown primary show better prognosis than those of known primary: a systematic review and meta-analysis of observational studies","volume":"72","author":"Bae","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2022.11.040_bib5","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/jso.25302","article-title":"Melanoma of unknown primary","volume":"119","author":"Song","year":"2019","journal-title":"J Surg Oncol"},{"issue":"2","key":"10.1016\/j.jaad.2022.11.040_bib6","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.critrevonc.2010.04.007","article-title":"Malignant melanoma of unknown primary site. To make the long story short. A systematic review of the literature","volume":"78","author":"Kamposioras","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1016\/j.jaad.2022.11.040_bib7","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4065\/74.1.62","article-title":"Primary pulmonary melanoma: case report and literature review","volume":"74","author":"Ost","year":"1999","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"10.1016\/j.jaad.2022.11.040_bib8","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3109\/00313027409077346","article-title":"Naevus cells in lymph nodes","volume":"6","author":"McCarthy","year":"1974","journal-title":"Pathology"},{"issue":"11","key":"10.1016\/j.jaad.2022.11.040_bib9","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/1097-0142(196511)18:11<1399::AID-CNCR2820181104>3.0.CO;2-R","article-title":"Spontaneous regression of primary malignant melanomas with regional metastases","volume":"18","author":"Smith","year":"1965","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.jaad.2022.11.040_bib10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/jso.2930230104","article-title":"Metastatic malignant melanoma of unknown primary origin: a study of 30 cases","volume":"23","author":"Panagopoulos","year":"1983","journal-title":"J Surg Oncol"},{"issue":"12","key":"10.1016\/j.jaad.2022.11.040_bib11","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1677139","article-title":"Patients with melanoma of unknown primary show better outcome under immune checkpoint inhibitor therapy than patients with known primary: preliminary results","volume":"8","author":"Gambichler","year":"2019","journal-title":"Oncoimmunology"},{"issue":"2","key":"10.1016\/j.jaad.2022.11.040_bib12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/00313027509092702","article-title":"Spontaneous regression of melanoma","volume":"7","author":"McGovern","year":"1975","journal-title":"Pathology"},{"issue":"1","key":"10.1016\/j.jaad.2022.11.040_bib13","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00000658-198001000-00018","article-title":"Clinical aspects of unknown primary melanoma","volume":"191","author":"Giuliano","year":"1980","journal-title":"Ann Surg"},{"key":"10.1016\/j.jaad.2022.11.040_bib14","series-title":"Melanoma of Unknown Primary. Noncutaneous Melanoma [Internet]","author":"Scott","year":"2018"},{"issue":"6","key":"10.1016\/j.jaad.2022.11.040_bib15","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/pcmr.12153","article-title":"Melanomas of unknown primary have a mutation profile consistent with cutaneous sun-exposed melanoma","volume":"26","author":"Dutton-Regester","year":"2013","journal-title":"Pigment Cell Melanoma Res"},{"issue":"13","key":"10.1016\/j.jaad.2022.11.040_bib16","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1245\/s10434-014-3799-y","article-title":"Molecular characterization and patient outcome of melanoma nodal metastases and an unknown primary site","volume":"21","author":"Gos","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.jaad.2022.11.040_bib17","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/annonc\/mdt411","article-title":"Metastatic melanoma of unknown primary resembles the genotype of cutaneous melanomas","volume":"25","author":"Egberts","year":"2014","journal-title":"Ann Oncol"},{"issue":"21","key":"10.1016\/j.jaad.2022.11.040_bib18","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1200\/JCO.2008.18.9845","article-title":"Improved survival for stage IV melanoma from an unknown primary site","volume":"27","author":"Lee","year":"2009","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.jaad.2022.11.040_bib19","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1002\/cncr.21835","article-title":"Metastatic melanoma to lymph nodes in patients with unknown primary sites","volume":"106","author":"Cormier","year":"2006","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.jaad.2022.11.040_bib20","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1634\/theoncologist.2015-0522","article-title":"Prognosis of mucosal, uveal, acral, nonacral cutaneous, and unknown primary melanoma from the time of first metastasis","volume":"21","author":"Kuk","year":"2016","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.jaad.2022.11.040_bib21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/(SICI)1097-0142(19970701)80:1<60::AID-CNCR8>3.0.CO;2-J","article-title":"Metastatic melanoma of unknown primary origin shows prognostic similarities to regional metastatic melanoma: recommendations for initial staging examinations","volume":"80","author":"Schlagenhauff","year":"1997","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.jaad.2022.11.040_bib22","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1002\/ijc.28318","article-title":"Patients undergoing lymphadenectomy for stage III melanomas of known or unknown primary site do not differ in outcome","volume":"133","author":"Hughes","year":"2013","journal-title":"Int J Cancer"},{"issue":"15_suppl","key":"10.1016\/j.jaad.2022.11.040_bib23","doi-asserted-by":"crossref","first-page":"e21571","DOI":"10.1200\/JCO.2018.36.15_suppl.e21571","article-title":"Epidemiological study of unknown primary melanoma patients from the French national melanoma database RIC-Mel","volume":"36","author":"Varey","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2022.11.040_bib24","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejca.2020.02.021","article-title":"Survival of patients with advanced metastatic melanoma: the impact of MAP kinase pathway inhibition and immune checkpoint inhibition - update 2019","volume":"130","author":"Ugurel","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jaad.2022.11.040_bib25","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1200\/EDBK_199047","article-title":"Melanoma","volume":"38","author":"Ascierto","year":"2018","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"7","key":"10.1016\/j.jaad.2022.11.040_bib26","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1056\/NEJMoa1904059","article-title":"Five-year outcomes with Dabrafenib plus Trametinib in metastatic melanoma","volume":"381","author":"Robert","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jaad.2022.11.040_bib27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined nivolumab and ipilimumab or monotherapy in untreated melanoma","volume":"373","author":"Larkin","year":"2015","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jaad.2022.11.040_bib28","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.21.02229","article-title":"Long-term outcomes with nivolumab plus ipilimumab or nivolumab alone versus ipilimumab in patients with advanced melanoma","volume":"40","author":"Wolchok","year":"2022","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.jaad.2022.11.040_bib29","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1468955","article-title":"Immunological effects of BRAF+MEK inhibition","volume":"7","author":"Ascierto","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jaad.2022.11.040_bib30","first-page":"341","article-title":"Malignant melanoma of unknown primary origin","volume":"117","author":"Das Gupta","year":"1963","journal-title":"Surg Gynecol Obstet"},{"issue":"2","key":"10.1016\/j.jaad.2022.11.040_bib31","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"11","key":"10.1016\/j.jaad.2022.11.040_bib32","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1007\/s00262-021-02871-1","article-title":"Clinical outcome of patients with metastatic melanoma of unknown primary in the era of novel therapy","volume":"70","author":"Verver","year":"2021","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jaad.2022.11.040_bib33","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1200\/JCO.2007.14.0285","article-title":"Improved survival after lymphadenectomy for nodal metastasis from unknown primary melanoma","volume":"26","author":"Lee","year":"2008","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.jaad.2022.11.040_bib34","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1002\/ijc.32631","article-title":"The real-world outcome of metastatic melanoma: unknown primary vs. known cutaneous","volume":"145","author":"Ellebaek","year":"2019","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.jaad.2022.11.040_bib35","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1684\/ejd.2020.3929","article-title":"Survival and therapeutic response in patients with melanoma of unknown and known primary: a single-centre retrospective analysis","volume":"30","author":"Ludwig","year":"2020","journal-title":"Eur J Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962222031425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962222031425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:08:34Z","timestamp":1759273714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962222031425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0190962222031425"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2022.11.040","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of systemic therapies in metastatic melanoma of unknown primary: A study from MELBASE, a French multicentric prospective cohort","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2022.11.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}